Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2026 | Q4 | $1.2M | -- | -- | -$0.23 | -- |
| 10/28/2025 | Q3 | $889.9K | -- | -$1.21 | -$0.34 | -$0.87 |
| 07/29/2025 | Q2 | $747.8K | -- | -$1.58 | -$0.18 | -$1.39 |
| 05/07/2025 | Q1 | $501.4K | -- | -$1.32 | -$0.24 | -$1.08 |
| 03/24/2025 | Q4 | $1.1M | -- | -$1.14 | -$0.22 | -$0.92 |
| 11/06/2024 | Q3 | $1.1M | -- | -$1.58 | -$1.77 | $0.19 |
| 07/30/2024 | Q2 | $1.7M | -- | -$1.72 | -$2.85 | $1.13 |
| 05/07/2024 | Q1 | $1.8M | -- | -$1.42 | -$2.25 | $0.83 |
| 03/07/2024 | Q4 | $1.2M | -- | -$0.58 | -$2.63 | $2.05 |
| 10/31/2023 | Q3 | -- | -- | -$0.87 | -- | -- |
| 07/31/2023 | Q2 | -- | -- | -$1.29 | -- | -- |
| 05/04/2023 | Q1 | -- | -- | -$1.09 | -- | -- |
| 03/02/2023 | Q4 | -- | -- | -$2.09 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$0.92 | -- | -- |
| 08/01/2022 | Q2 | -- | -- | -$1.74 | -- | -- |
| 05/02/2022 | Q1 | -- | -- | -$1.52 | -- | -- |
| 02/24/2022 | Q4 | -- | -- | -$1.24 | -- | -- |
| 10/26/2021 | Q3 | -- | -- | -$2.19 | -- | -- |
| 08/02/2021 | Q2 | -- | -- | -$2.79 | -- | -- |
| 05/03/2021 | Q1 | -- | -- | -$2.68 | -- | -- |
| 03/05/2021 | Q4 | -- | -- | -$3.60 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$2.80 | -- | -- |
| 07/31/2020 | Q2 | -- | -- | -$4.40 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$3.95 | -- | -- |
| 03/04/2020 | Q4 | -- | -- | -$5.36 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$4.07 | -- | -- |
| 08/01/2019 | Q2 | -- | -- | -- | -$1.05 | -- |
| 03/31/2019 | Q1 | -- | -- | -- | -$1.36 | -- |
| 03/05/2019 | Q4 | -- | -- | -$9.24 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$8.56 | -- | -- |
| 09/07/2018 | Q2 | -- | -- | -- | -$0.99 | -- |
| 03/31/2018 | Q1 | -- | -- | -- | -$1.16 | -- |
| 03/14/2018 | Q4 | -- | -- | -- | -$2.17 | -- |
| 09/30/2017 | Q3 | -- | -- | -- | -$2.09 | -- |
| 07/28/2017 | Q2 | -- | -- | -$1.45 | -$1.83 | $0.38 |
| 03/31/2017 | Q1 | -- | -- | -- | -$1.23 | -- |
| 03/15/2017 | Q4 | -- | -- | -- | -- | -- |
| 07/28/2016 | Q2 | -- | -- | -- | -- | -- |
| 04/07/2016 | Q1 | -- | -- | -- | -- | -- |
| 04/06/2016 | Q4 | -- | -- | -- | -- | -- |
DBV Technologies SA reported -- worth of top line sales in its most recent quarter.
DBV Technologies SA announced earnings per share of -$1.21 which represents a miss of analyst forecast a -$0.34 per share.
DBV Technologies SA reported -$4.3M that represents -$0.16 per share over the last quarter.
DBV Technologies SA's earnings are forecast to decrease from -$5.86 per share to -$1.16 per share next year representing a decrease of -82.76%.
DBV Technologies SA's next earnings date is March 23, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.